Health & bio
Foundayo Oral GLP-1 FDA Approval (April 1)
FDA approved Foundayo for obese and overweight adults—the first oral GLP-1 receptor agonist requiring no food/water constraints before dosing.
Primary sources · 1
FDA approved Foundayo for obese and overweight adults—the first oral GLP-1 receptor agonist requiring no food/water constraints before dosing.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.